These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11033665)

  • 1. Quality and cost effectiveness in health care: a unique approach.
    Brown GC; Brown MM; Sharma S
    J Ophthalmic Nurs Technol; 2000; 19(1):26-30. PubMed ID: 11033665
    [No Abstract]   [Full Text] [Related]  

  • 2. Decision making the explicit evidence-based way: comparing benefits, harms and costs.
    McArthur J; Dickinson A
    Nurs Prax N Z; 1999 Mar; 14(1):33-42. PubMed ID: 10481662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methods for cost-effectiveness evaluation of intensive care].
    Heslet L; Andersen JS; Keiding H
    Ugeskr Laeger; 2007 Feb; 169(8):721-4. PubMed ID: 17313927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scientific evidence in clinical practice: cost-effective and guaranteed quality of care].
    Gulácsi L
    Orv Hetil; 2002 Aug; 143(32):1879-85. PubMed ID: 12221993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value-based medicine: the new paradigm.
    Brown GC
    Curr Opin Ophthalmol; 2005 Jun; 16(3):139-40. PubMed ID: 15870569
    [No Abstract]   [Full Text] [Related]  

  • 8. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
    Dougherty EJ
    Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Authority for Health: France.
    Rochaix L; Xerri B
    Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It is time for physicians to embrace cost-effectiveness and cost utility analysis research in the treatment of spinal pain.
    Dagenais S; Haldeman S; Polatin PB
    Spine J; 2005; 5(4):357-60. PubMed ID: 15996604
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness.
    Brown GC; Brown MM
    Curr Opin Ophthalmol; 2009 May; 20(3):147-50. PubMed ID: 19387344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness.
    Tuulonen A; Azuara-Blanco A
    Ophthalmology; 2009 Jan; 116(1):166-7; author reply 167. PubMed ID: 19118707
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness.
    Brown GC; Brown MM
    Ophthalmology; 2008 Aug; 115(8):1433; author reply 1433-4. PubMed ID: 18675701
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence based medicine and cost-effectiveness analysis in ophthalmology].
    Nováková D; Rozsíval P
    Cesk Slov Oftalmol; 2004 Sep; 60(5):335-41. PubMed ID: 15566221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of quality-adjusted life-years in cost-effectiveness studies.
    Sculpher M
    Allergy; 2006 May; 61(5):527-30. PubMed ID: 16629779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.